Author： Borriello Manuela Stasi Luigi Piero
Publisher： Future Science
ISSN： 2046-8954
Source： Pharmaceutical Patent Analyst, Vol.2, Iss.3, 2013-05, pp. : 387-397
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Novel EP1 receptor antagonists
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. :
Access to resources
Recommend
Prostaglandin EP receptor subtypes and gastric cytoprotection
By Takeuchi Koji Hase Shoko Takeeda Masanori Nakashima Masato Yokota Aya
Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. :
Current Pharmaceutical Design, Vol. 8, Iss. 14, 2002-06 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. :